MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin

Background: Platinum-based chemotherapy, cisplatin (DDP) specifically, is the main strategy for treating lung cancer (LC). However, currently, there is a lack of predictive drug-resistance markers, and there is increased interest in the development of a reliable and sensitive panels of markers for D...

Descripción completa

Detalles Bibliográficos
Autores principales: Konoshenko, Maria, Lansukhay, Yuriy, Krasilnikov, Sergey, Laktionov, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321818/
https://www.ncbi.nlm.nih.gov/pubmed/35886942
http://dx.doi.org/10.3390/ijms23147594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321818/
https://www.ncbi.nlm.nih.gov/pubmed/35886942
http://dx.doi.org/10.3390/ijms23147594

Ejemplares similares